Literature DB >> 26278294

Takotsubo Cardiomyopathy Triggered by Influenza A Virus.

Julie Buzon1, Ombeline Roignot, Simon Lemoine, Pierre Perez, Antoine Kimmoun, Bruno Levy, Emmanuel Novy.   

Abstract

We herein report the first case of Takotsubo cardiomyopathy triggered by influenza A virus. Myocardial involvement in influenza virus infection has been described in 10% of cases. The literature has principally reported cases of acute myocarditis ranging from asymptomatic to fulminant heart failure and cardiac tamponade. Takotsubo cardiomyopathy frequently occurs in the setting of significant emotional or physical stress or acute medical illness, with a predominance in postmenopausal women. We report the diagnosis, management and outcomes presented in this case, with the aim of describing a new cardiovascular complication of influenza virus infection.

Entities:  

Mesh:

Year:  2015        PMID: 26278294     DOI: 10.2169/internalmedicine.54.3606

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  18 in total

1.  A case of Takotsubo cardiomyopathy with cardiogenic shock after influenza infection successfully recovered by IMPELLA support.

Authors:  Makiko Nakamura; Masaki Nakagaito; Masakazu Hori; Hiroshi Ueno; Koichiro Kinugawa
Journal:  J Artif Organs       Date:  2019-06-21       Impact factor: 1.731

Review 2.  Considerations When Managing Heart Failure during the COVID-19 Pandemic-Consensus from the Taiwan Society of Cardiology.

Authors:  Kun-Chang Lin; Chun-Chieh Wang; Wei-Chun Huang; Juey-Jen Hwang
Journal:  Acta Cardiol Sin       Date:  2021-03       Impact factor: 2.672

Review 3.  Cardiac Involvement in COVID-19-Assessment with Echocardiography and Cardiac Magnetic Resonance Imaging.

Authors:  Riccardo Cau; Pierpaolo Bassareo; Luca Saba
Journal:  SN Compr Clin Med       Date:  2020-06-10

4.  Cardiovascular impact of COVID-19: an array of presentations.

Authors:  Hira Maab; Faryal Mustafa; Syeda Javeria Shabbir
Journal:  Acta Biomed       Date:  2021-05-12

5.  Mitigating the Risk of COVID-19 Deaths in Cardiovascular Disease Patients in Africa Resource Poor Communities.

Authors:  Ihunanya Chinyere Okpara; Efosa Kenneth Oghagbon
Journal:  Front Cardiovasc Med       Date:  2021-02-16

Review 6.  Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes.

Authors:  Emmanouil Korakas; Ignatios Ikonomidis; Foteini Kousathana; Konstantinos Balampanis; Aikaterini Kountouri; Athanasios Raptis; Lina Palaiodimou; Alexander Kokkinos; Vaia Lambadiari
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-27       Impact factor: 4.310

7.  Stressing Out from the Flu: A Case of Influenza A-associated Transient Cardiomyopathy.

Authors:  Erika L Faircloth; Sarfaraz Memon
Journal:  Cureus       Date:  2019-06-17

Review 8.  Cardiovascular complications in COVID-19.

Authors:  Brit Long; William J Brady; Alex Koyfman; Michael Gottlieb
Journal:  Am J Emerg Med       Date:  2020-04-18       Impact factor: 2.469

Review 9.  Cardiovascular Complications Related to COVID-19 Disease.

Authors:  Raed A Alsatli
Journal:  Anesth Essays Res       Date:  2021-03-22

10.  [Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology].

Authors:  Clara Bonanad; Sergio García-Blas; Francisco José Tarazona-Santabalbina; Pablo Díez-Villanueva; Ana Ayesta; Juan Sanchis Forés; María Teresa Vidán-Austiz; Francesc Formiga; Albert Ariza-Solé; Manuel Martínez-Sellés
Journal:  Rev Esp Cardiol       Date:  2020-04-03       Impact factor: 4.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.